Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

被引:220
|
作者
Stolk, Elly [1 ]
Ludwig, Kristina [1 ,2 ]
Rand, Kim [3 ,4 ]
van Hout, Ben [5 ]
Ramos-Goni, Juan Manuel [1 ]
机构
[1] EuroQol Res Fdn, Marten Meesweg 107, NL-3068 AV Rotterdam, Netherlands
[2] Bielefeld Univ, Hlth Econ & Hlth Care Management, Bielefeld, Germany
[3] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[4] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
[5] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
关键词
discrete choice experiment; EQ-5D-5L; health valuation; time trade-off; utilities; VALUE SET; HEALTH; UTILITY; MULTIATTRIBUTE; VALUES; INDEX;
D O I
10.1016/j.jval.2018.05.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set of problems encountered in this initial wave of valuation studies led to the subsequent refinement of the valuation protocol. To clarify lessons learned and how the protocol was updated when moving from version 1.0 to the current version 2.1 and 2.0, this article will (1) present the challenges faced in EQ-5D-5L valuation since 2012 and how these were resolved and (2) describe in depth a set of new challenges that have become central in currently ongoing research on how EQ-5D-5L health states should be valued and modeled. Copyright (c) 2019, ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [31] COVID-19 and EQ-5D-5L health state valuation
    Webb, Edward J. D.
    Kind, Paul
    Meads, David
    Martin, Adam
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (01): : 117 - 145
  • [32] Determinants of health preferences in the Canadian EQ-5D-5L Valuation Study
    Al Sayah, Fatima
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Pullenayegum, Eleanor
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2015, 24 : 177 - 178
  • [33] RETRACTED: The EQ-5D-5L Valuation Study in Egypt (Retracted Article)
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    PHARMACOECONOMICS, 2021, 39 (05) : 549 - 561
  • [34] Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of cTTO and DCE
    Augustovski, Federico
    Belizan, Maria
    Gibbons, Luz
    Reyes, Nora
    Stolk, Elly
    Craig, Benjamin M.
    Tejada, Romina A.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (01): : 140 - 141
  • [35] COVID-19 and EQ-5D-5L health state valuation
    Edward J. D. Webb
    Paul Kind
    David Meads
    Adam Martin
    The European Journal of Health Economics, 2024, 25 : 117 - 145
  • [36] Quality control of the data on the Portuguese study for the valuation of the EQ-5D-5L
    Antunes, Patricia
    Ferreira, Pedro Lopes
    Ferreira, Lara Noronha
    Pereira, Luis
    QUALITY OF LIFE RESEARCH, 2018, 27 : S62 - S62
  • [37] EQ-5D-5L VALUATION PROJECT FOR THE SPANISH POPULATION - A DESCRIPTIVE OVERVIEW AND PRELIMINARY RESULTS
    Ramos-Goni, J.
    Errea, M.
    Rivero-Arias, O.
    Cabases, J. M.
    Pinto, J. L.
    VALUE IN HEALTH, 2012, 15 (07) : A279 - A279
  • [38] Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
    Rencz, Fanni
    Brodszky, Valentin
    Gulacsi, Laszlo
    Golicki, Dominik
    Ruzsa, Gabor
    Pickard, A. Simon
    Law, Ernest H.
    Pentek, Marta
    VALUE IN HEALTH, 2020, 23 (09) : 1235 - 1245
  • [39] Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets
    Law, Ernest H.
    Pickard, A. Simon
    Xie, Feng
    Walton, Surrey M.
    Lee, Todd A.
    Schwartz, Alan
    MEDICAL DECISION MAKING, 2018, 38 (08) : 968 - 982
  • [40] Mapping EQ-5D-3L to EQ-5D-5L
    van Hout, Ben A.
    Shaw, James W.
    VALUE IN HEALTH, 2021, 24 (09) : 1285 - 1293